...KRAS are shared between endometriosis and certain OC subtypes, and the nature of the environment typical of ovarian endo...
...KRAS G12C inhibitor, has demonstrated substantial clinical efficacy in KRAS G12C-mutant malignancies but is frequently a...
...KRAS-mutant PDAC. To address the need for novel inhibitors, we implemented an integrated virtual screening workflow comb...
...KRAS proteins. Notably, stabilization of the p-loop and substitution toward Leu 95 while maintaining key interactions wi...
...KRAS G12C, and 15% (n = 3) were the EGFR E19del. Overall, 15.27% (n = 20) of EBUS-TBNA procedures for primary lung cance...
...KRAS (10.0%). EGFR mutations showed a strong female predominance (P<0.001), whereas MUC16 (P=0.004) and KRAS (P<0.001) a...
...KRAS) affecting treatment response. While genetic testing remains the gold standard for mutation detection, it is invasi...
...KRAS, and twelve genes not previously associated with focal epilepsy. Eight Ras-MAPK genes showed positive clonal select...
...Kras G12D Mu/Wt. Control C57 mice were used as a comparison. Experimental and control mice underwent serial abdominal ma...
...KRAS, MYC, BRAF, and EGFR, and restoring the function of tumor suppressors including TP53, RB1, and PTEN. The review fur...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269